Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Osteoporosis (Drug Development)
What Can We Learn from Bone Biology for the Treatment of Osteoporosis?
September 28th, 1998
According to an abstract submitted by the author to the European Congress on Osteoporosis, held September 11-15, 1998, in Berlin, Germany, "The current treatments for osteoporosis have mostly been identified by serendipity. None have been developed based on the classical drug discovery process of identifying a key molecular target, and then utilizing this molecular target for screening of small molecules in order to identify an orally available and acceptable agent with appropriate pharmacokinetic qualities. Agents such as bisphosphonates, estrogen and estrogen-related compounds, fluoride, and parathyroid hormone all work through mechanisms which have not been clearly identified and...
Source: Women's Health Weekly (1998-09-28)
|
|
Advertisement |
|
|
